Osmotica Pharmaceuticals PLC reports results for the quarter ended in March - Earnings Summary

RVL Pharmaceuticals

15/05/2021 17:00

* Osmotica Pharmaceuticals PLC  OSMT.OQ  reported a quarterly
adjusted loss of 15 cents​​ per share for the quarter ended
in March. The mean expectation of three analysts for the quarter
was for a loss of 23 cents per share.
* Revenue fell 50.9% to $23.88 million from a year ago; 
analysts expected $30.65 million. 
* Osmotica Pharmaceuticals PLC's reported EPS for the quarter
was a loss of 15 cents​.
* The mean earnings estimate of analysts had risen by
about 10.8% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Osmotica Pharmaceuticals PLC shares had fallen by 5.8% this
quarter and lost 25.5% so far this year.
* The company reported a quarterly loss of $9.61 million.
* Wall Street's median 12-month price target for Osmotica
Pharmaceuticals PLC is $7.50 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
This summary was machine generated May 15 at 04:00 p.m. GMT.
​All figures in US dollars